L-对苯甲酰基苯丙氨酸 | 104504-45-2

• 物质功能分类: 生物化工 - 氨基酸及其衍生物 - 丙氨酸类衍生物
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: L-对苯甲酰基苯丙氨酸
• 中文别名: 4-苯甲酰基-L-苯丙氨酸；L-4-苯甲酰基苯丙氨酸；4-苯甲酰基-L-苯基丙氨酸
• 英文名称: p-Benzoyl-DL-Phenylalanine
• 英文别名: p-Benzoyl-L-phenylalanine；(2S)-2-amino-3-(4-benzoylphenyl)propanoic acid；L-(S)-4-(benzoyl)phenylalanine；4-Benzoyl-L-phenylalanine；4-benzoylphenylalanine
• CAS: 104504-45-2
• 化学式: C₁₆H₁₅NO₃
• 分子量: 269.3
• InChiKey: TVIDEEHSOPHZBR-AWEZNQCLSA-N

物化性质

• 沸点：
  467.6±40.0 °C(Predicted)
• 密度：
  1.249±0.06 g/cm3(Predicted)
• 溶解度：
  DMF: 不溶； DMSO: 不溶；乙醇：insol； PBS (pH 7.2)：不溶

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  20
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  84.8
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2922509090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335
• 储存条件：
  2-8°C

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: L-4-Benzoylphenylalanine
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: L-4-Benzoylphenylalanine
CAS number: 104504-45-2

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C16H15NO3
Molecular weight: 269.3

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

(-2)-氨基-3-(4-苯甲酰苯基)丙酸是一种丙氨酸衍生物[1]。

反应信息

• 作为反应物：
  描述：

  L-对苯甲酰基苯丙氨酸 在 盐酸 、 乙酸酐 作用下， 以 sodium hydroxide 为溶剂， 以38.04 g (80%)的产率得到N-Acetyl-p-Benzoyl-DL-Phenylalanine
  参考文献：
  名称：

  Photoreactive benzoylphenylalanines and related peptides

  摘要：

  提供的是一种分子式为：##STR1##的苯甲酰苯丙氨酸，其中##STR2##位于m或p位置；Pr是一种易于在缓和酸或碱的存在下被裂解的保护基团。这种苯甲酰苯丙氨酸基团被纳入到可以通过暴露于低能紫外光而连接到具有反应性氢的固体基质上的肽链中。

  公开号：

  US04762881A1
• 作为产物：
  描述：

  methyl (2S)-3-(4-benzoylphenyl)-2-[(2,2,2-trifluoroacetyl)amino]propanoate 在 sodium hydroxide 作用下， 以 甲醇 、 水 、 乙腈 为溶剂， 生成 L-对苯甲酰基苯丙氨酸
  参考文献：
  名称：

  使用三氟甲磺酸中的 Friedel-Crafts 反应简单且立体控制地制备苯甲酰化苯丙氨酸用于光亲和标记

  摘要：

  报道了在三氟甲磺酸 (TfOH) 中使用 Friedel-Crafts 反应从光学纯苯丙氨酸简单且立体可控地制备苯甲酰化苯丙氨酸衍生物；这些衍生物可用于光亲和标记。在室温下，受保护或未受保护的苯丙氨酸衍生物在 TfOH 中短时间内转化为苯甲酰基衍生物，而不会损失光学纯度。应用该反应条件合成了具有两种发光体（二苯甲酮和二氮丙啶）的新型光反应性苯丙氨酸衍生物。还研究了含有苯丙氨酸衍生物的两种不同发光体的光辐照的详细分析。光亲和标记是研究生物活性分子与其靶蛋白相互作用的一种有价值的化学方法。在光亲和标记中，在紫外光照射下，配体和靶蛋白之间形成共价键。例如，为了研究目标蛋白的生物活性肽相互作用，需要光反应性 α-氨基酸，它是光亲和标记的强大探针。据报道，二苯甲酮的制备含有 α-氨基酸衍生物，这些衍生物是由二苯甲酮的卤代甲基衍生物和 α-氨基丙二酸酯等价物使用外消旋或不对称方法合成的（图 1A）。但

  DOI：

  10.3987/com-13-12815

文献信息

• [EN] HYBRID MU OPIOID RECEPTOR AND NEUROPEPTIDE FF RECEPTOR BINDING MOLECULES, THEIR METHODS OF PREPARATION AND APPLICATIONS IN THERAPEUTIC TREATMENT<br/>[FR] RÉCEPTEUR D'OPIOÏDE MU HYBRIDE ET MOLÉCULES DE LIAISON DE RÉCEPTEUR DE NEUROPEPTIDE FF, LEURS PROCÉDÉS DE PRÉPARATION ET D'APPLICATIONS DANS UN TRAITEMENT THÉRAPEUTIQUE
  申请人：CENTRE NAT RECH SCIENT

  公开号：WO2019170919A1

  公开（公告）日：2019-09-12

  The present invention relates to molecules binding the mu opioid receptor (MOR) and the neuropeptide FF receptor (NPFFR) and in particular molecules having a MOR agonist and NPFFR modulatory activity. The present invention relates to pharmaceutical compositions, and in particular useful in the treatment of pain and/or hyperalgesia.

  本发明涉及结合μ阿片受体（MOR）和神经肽FF受体（NPFFR）的分子，特别是具有MOR激动剂和NPFFR调节活性的分子。本发明涉及药物组合物，特别是在治疗疼痛和/或过敏症方面有用。
• CHIMERIC MELANOCORTIN LIGANDS AND METHODS OF USE THEREOF
  申请人：REGENTS OF THE UNIVERSITY OF MINNESOTA

  公开号：US20180118789A1

  公开（公告）日：2018-05-03

  The invention provides compounds having the general formula I: and salts thereof, wherein the variables Pro, DPro, DPhe, Arg, Trp, X 1 , X 2 , X 3 and X 4 have the meaning as described herein, and compositions containing such compounds and methods for using such compounds and compositions.

  这项发明提供了具有一般式I的化合物及其盐，其中变量Pro、DPro、DPhe、Arg、Trp、X1、X2、X3和X4的含义如本文所述，并包含这种化合物的组合物以及使用这种化合物和组合物的方法。
• BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE
  申请人：Arvinas Operations, Inc.

  公开号：US20190300521A1

  公开（公告）日：2019-10-03

  The present disclosure relates to bifunctional compounds, which find utility as modulators of SMARCA2 or BRM (target protein). In particular, the present disclosure is directed to bifunctional compounds, which contain on one end a ligand that binds to the Von Hippel-Lindau E3 ubiquitin ligase, and on the other end a moiety which binds the target protein, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of target protein. The present disclosure exhibits a broad range of pharmacological activities associated with degradation/inhibition of target protein. Diseases or disorders that result from aggregation or accumulation of the target protein are treated or prevented with compounds and compositions of the present disclosure.

  本公开涉及双功能化合物，其作为SMARCA2或BRM（靶蛋白）的调节剂具有实用性。具体而言，本公开涉及包含一端结合Von Hippel-Lindau E3泛素连接酶的配体，另一端结合靶蛋白的双功能化合物，使得靶蛋白与泛素连接酶靠近以实现靶蛋白的降解（和抑制）。本公开展示了与靶蛋白降解/抑制相关的广泛药理活性。本公开的化合物和组合物用于治疗或预防由靶蛋白聚集或积累导致的疾病或紊乱。
• Pyrroloquinolones as antiviral agents
  申请人：——

  公开号：US20020055636A1

  公开（公告）日：2002-05-09

  The present invention provides a compound of formula I 1 which is useful as antiviral agents, in particular, as agents against viruses of the herpes family.

  本发明提供了一种化合物，其化学式为I，可用作抗病毒剂，特别是用于抗击疱疹病毒家族的药剂。
• [EN] PYRIMIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE<br/>[FR] COMPOSÉS DE PYRIMIDINE, COMPOSITIONS ET PROCÉDÉS D'UTILISATION
  申请人：GENENTECH INC

  公开号：WO2010014939A1

  公开（公告）日：2010-02-04

  Disclosed are compounds of Formula I, including steroisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, that are useful in modulating PIKK related kinase signaling, e.g., mTOR, and for the treatment of diseases (e.g., cancer) that are mediated at least in part by the dysregulation of the PIKK signaling pathway (e.g., mTOR).

  揭示了公式I的化合物，包括立体异构体、几何异构体、互变异构体、溶剂合物、代谢物和其药学上可接受的盐，这些化合物在调节PIKK相关激酶信号传导方面很有用，例如mTOR，并用于治疗至少部分由PIKK信号传导途径失调引起的疾病（例如癌症）。